- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05783843
Comparison of Text and Pictorial Waterpipe Tobacco Warnings Among Young Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest University Health Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- United States (US) Resident
- Has used waterpipe tobacco within the past year (self-report) OR
- Has not used waterpipe tobacco within the past year but is susceptible to use (self-report)
Exclusion Criteria:
- Younger than 18 or older than 29
- Not a US Resident
- Has not used waterpipe tobacco within the past year and is not susceptible to use (self-report)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Pictorial Warnings
Waterpipe tobacco packages shown with pictorial warnings about health harms of waterpipe smoking
|
Participants will be shown 6 waterpipe tobacco packages with 6 different pictorial warnings about the health harms of waterpipe smoking.
The order of the 6 packages within this trial arm will be randomized.
Study investigators developed a fictitious waterpipe tobacco brand to be used in this study and designed the warnings for this arm.
|
|
Experimental: Text Warnings
Waterpipe tobacco packages shown with text-only warning about health harms of waterpipe smoking
|
Participants will be shown 6 waterpipe tobacco packages with 6 different text-only warnings about the health harms of waterpipe smoking.
The order of the 6 packages within this trial arm will be randomized.
Study investigators developed a fictitious waterpipe tobacco brand to be used in this study and designed the warnings for this arm.
|
|
Experimental: No Warnings (Control)
Waterpipe tobacco package shown without a warning
|
Participants will be shown a single package without a warning.
Study investigators developed a fictitious waterpipe tobacco brand to be used in this study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Behavioral Intentions
Time Frame: Minute 2
|
The primary outcome is intention to smoke tobacco in a waterpipe within the next year, measured by averaging three items to create a composite score (adapted from research on cigarette smoking). The primary outcome will be measured after the exposure to waterpipe packages. Score ranges from 1-5 with higher score indicating greater intention to smoke hookah.
|
Minute 2
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Product Appeal
Time Frame: Minute 2
|
Three items will be used to measure how appealing each waterpipe tobacco package is to respondents, how likely they would be to try the product, and how much the packaging makes the respondent think that the product is harmful.
|
Minute 2
|
|
Perceived Message Effectiveness
Time Frame: Minute 2
|
This outcome will be measured using the 3-item Perceived Measured Effectiveness scale created by Noar and colleagues that includes items on attitudes, risk beliefs, and intentions. Mean scores will be calculated.
|
Minute 2
|
|
Attention
Time Frame: Minute 1
|
One item to measure self-reported attention to the warning. 1. How much does this warning grab your attention? Response scale: (1) Not at all / (2) Very little / (3) Somewhat / (4) Quite a bit / (5) A great deal |
Minute 1
|
|
Emotional Reactions
Time Frame: Minute 2
|
Three items to measure negative emotional reactions to the warning that the participant saw. Mean scores will be calculated.
|
Minute 2
|
|
Cognitive Elaboration
Time Frame: Minute 1
|
One item to measure the extent to which a participant reports the warning making them think about the risks of hookah smoking. 1. How much does this warning make you think about the health effects of smoking hookah? Response scale: (1) Not at all / (2) Very little / (3) Somewhat / (4) Quite a bit / (5) A great deal |
Minute 1
|
|
Self-reported Learning
Time Frame: Minute 1
|
One item to measure the extent to which respondents learned something new from the warning. 1. To what extent did you learn something new from this warning that you did not already know? Response Scale: (1) Not at all / (2) Very little / (3) Somewhat / (4) Quite a bit / (5) A great deal |
Minute 1
|
|
Social Interactions
Time Frame: Minute 1
|
One item to measure self-reported likelihood of discussing the warning shown with one's social contacts within the week following the survey. 1. How likely are you to talk about this warning with others in the next week? Response Scale: (1) Not at all / (2) Very little / (3) Somewhat / (4) Quite a bit / (5) A great deal |
Minute 1
|
|
Knowledge
Time Frame: Minute 3
|
Six items to measure knowledge of the potential health harms described by the warnings.
|
Minute 3
|
|
Beliefs
Time Frame: Minute 3
|
Five items to measure the respondent's belief of their own risk of experiencing each of the warning health harms. One item measures risk to pregnant people, rather than the self, since this item will be administered to all participants.
|
Minute 3
|
|
Worry
Time Frame: Minute 3
|
Five/six items measuring a respondent's concern about their risk of warning health effects. Damage to fetuses will only be asked of respondents who report female sex at birth.
|
Minute 3
|
|
Quit Motivation
Time Frame: Minute 1
|
Participants who report past-year use will report, on a scale of 1-10, how motivated they are to quit smoking hookah.
|
Minute 1
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Erin Sutfin, PhD, Wake Forest University Health Sciences
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB00091946
- R01CA241420 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Waterpipe Tobacco Smoking
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedWaterpipe Tobacco SmokingUnited States
-
University of OklahomaNational Institute on Drug Abuse (NIDA); American University of Beirut Medical... and other collaboratorsCompletedWaterpipe Smoking | Smoking, HookahUnited States
-
Florida International UniversityCompleted
-
Washington State UniversityCompleted
-
San Diego State UniversityCompleted
-
Ataturk Training and Research HospitalCompletedOxidative Stress | Waterpipe Smoking
-
Rambam Health Care CampusCompletedWaterpipe SmokingIsrael
-
Florida International UniversityCompletedHealth Risk Behaviors | Waterpipe Smoking | Health Warning Label | Harm Perception | Puffing Behaviour | Quitting SmokingUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
Clinical Trials on Pictorial Warnings
-
Boston UniversityNational Cancer Institute (NCI); Brown University; National Institutes of Health... and other collaboratorsCompleted
-
University of South CarolinaCornell University; University of Waterloo; University of TasmaniaCompleted
-
Boston UniversityNational Cancer Institute (NCI); Brown University; Wake Forest University Health...Completed
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Food and Drug Administration (FDA)Completed
-
Hitotsubashi UniversityGlobal Public Health Research FoundationRecruitingHypertension | Tobacco Cessation | Health Warning Label | Non Communicable Chronic DiseasesBangladesh
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
University of MiamiEnrolling by invitation
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Imperial College LondonCompletedAsthma | COPDUnited Kingdom